State Pharmaceuticals Corporation

logo
Type
State Owned Enterprise
Industry
Health

With the largest market share in the industry supplying pharmaceuticals to the nation, SPC’s national role is to serve Sri Lanka by providing safe, efficacious and high quality medicinal products and health services at affordable prices, while promoting the usage of generic drugs. Its services include the Procurement and Supply of Drugs, Laboratory Work, and Awareness Programmes. Its first segment involves distributing drugs to both the private sector market through an open competitive tender procedure and the general public through the State Pharmaceuticals Corp network of Rajya Osu Salas, and other distributors. Its Laboratory work includes testing the drugs, and its Awareness Programmes, which include Programmes for the general public via TV Programmes and brochures, are dedicated to educate people on proper and rational use of drugs and preventive health care. SPC was founded in 1971 and is headquartered in Colombo.

ROA
2.9
Governance
45.8
Profits/Losses
LKR 1,623,407

Governance Indicators

A systematic measure of how well this SOE is managed.

2019

Year of the most recent Annual Report available online

1

Have Annual Reports for the last five years been tabled in Parliament?

1

Does the Annual Report include the mandatory provisions set out in the PED guidelines?

1

Is the Audit Clean / Qualified / Disclaimer?

0

Is the information pertaining to the RTI officer available on the website?

0

Does the SOE respond to an RTI within the timeframe specified in the Act?

1

Does the SOE have a website?

1

Does the SOE website contain sufficient organtisational details?

1

Does the SOE website contain tender and procurement details?

Annual Report
Auditing Standards
Rights to Information
Accessibility of Information

Interpretation of the indicators

Good
2
Average
1
Bad
0

Financials

Available Financial data for the last few years.

Year Turnover (LKR) Total Assets Profit/Loss Total Debt Total Liabilities Total Equity Operational Profits ROA
2024
62,087,499
54,480,572
1,623,407
4,299,021
40,585,797
13,894,775
4,225,617
2.9
2023
74,695,070
56,706,999
773,535
5,901,912
43,843,011
12,863,988
4,550,387
1.4
2022
50,918,967
66,276,467
644,723
8,004,715
51,691,442
14,585,025
860,903
1
2021
80,258,167
58,936,925
2,384,564
9,904,472
44,161,127
14,775,798
3,729,973
4.8
2020
63,122,706
41,404,070
1,969,224
11,908,162
29,070,274
12,333,796
3,236,200
5.2
2019
51,884,510
33,828,008
1,663,869
294,459
23,271,680
10,556,328
2,497,452
5.9

Download our datasets

Access Advocata Institute's Datasets on State Owned Enterprises